Skip to main content
. 2003 May 22;361(9371):1767–1772. doi: 10.1016/S0140-6736(03)13412-5

Table 4.

Subsequent analysis of clinical samples of 20 patients with initial RT-PCR-positive nasopharyngeal aspirates and antibody seroconversion to SARS-associated coronavirus

Time after onset of symptoms (days; n=20)
10 13 16 19 21
Sample (positivity rate)
Nasopharyngeal aspirate 19 (95%) 18 (90%) 18 (90%) 15 (75%) 9 (47%)*
Stool 20 (100%) 20 (100%) 19 (95%) 12 (80%) 10 (67%)
Urine 10 (50%) 9 (45%) 7 (35%) 6 (30%) 4 (21%)*
*

in 19 patients.

In 15 patients